Pyrrole compounds as inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto

Details for Australian Patent Application No. 2005245885 (hide)

Owner Vertex Pharmaceuticals, Incorporated

Inventors Hale, Michael R.; Martinez-Botella, Gabriel; Straub, Judith; Tang, Qing; Maltais, Francois

Agent Cullens

Pub. Number AU-B-2005245885

PCT Pub. Number WO2005/113541

Priority 60/571,309 14.05.04 US

Filing date 13 May 2005

Wipo publication date 1 December 2005

Acceptance publication date 20 January 2011

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4439 (2006.01)

A61P 9/00 (1970.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 37/00 (1970.01) Drugs for immunological or allergic disorders

C07F 9/58 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/6558 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/113541 Priority application(s): WO2005/113541

20 January 2011 Application Accepted

  Published as AU-B-2005245885

19 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005245891-Blend compositions suitable for RF welding applications

2005245883-Nip press sensing system including a sensor strip having sensor interface electronics associated therewith and methods of operating the same